Let's take a close look at the share of the Chinese maker of premium smart electric SUVs.
Here I'll look at 'old school' and 'new school' approaches to betting against higher prices via exchange-traded funds.
Shares of Novavax are looking weak and in need of a booster, according to the technicals.
Sellers of ACN remain more aggressive than buyers.
Dual forces have combined to create a world in which hydrocarbons are in short supply, which makes the price of everything else rise.
INTU got a 'Buy' rating, but my view of the charts doesn't jibe with the fundamentalist's.
It's hard to buy 'because everyone is bearish' while the technical picture looks so rough.
This is a question investors and traders really need to ask themselves.
This is a story of declining margin in an inflationary environment.
The Fed hike broke chart support levels.